Sign in
8-K

Current Report

Indaptus Therapeutics, Inc. Filed Acc 0001493152-21-018935

Agreement ended · Acquisition or sale completed · Exit or restructuring costs · Impairment · Shareholder rights changed · Change in control · Bylaws or fiscal year change · Regulation FD disclosure

  • Item 1.02 Termination of a material definitive agreement
  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 2.05 Costs associated with exit or disposal activities
  • Item 2.06 Material impairments
  • Item 3.03 Material modification to rights of security holders
  • Item 5.01 Changes in control of the registrant
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading form8-k.htm…